Atlas Trials

Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity

Clinical trial NCT02390531 · COMPLETED

Trial details

NCT number
NCT02390531
Sponsor
Jaeb Center for Health Research
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Retinopathy of Prematurity
Start date
2015-04-28
Primary completion
2019-06-04
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.